T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
NovaGold Resources
NG
$3.4B
| $31.8M | ﹤0.01% |
3,618,865
+3,494,533
| +2,811% | +$21.4M |
|
|
OKLO
927
Oklo
OKLO
$8.64B
| $31.8M | ﹤0.01% |
285,280
+209,020
| +274% | +$16.4M |
|
928
Corcept Therapeutics
CORT
$11.9B
| $31.8M | ﹤0.01% |
383,060
+235,968
| +160% | +$17.1M |
|
929
GXO Logistics
GXO
$5.56B
| $31.8M | ﹤0.01% |
601,189
-301,368
| -33% | -$15.5M |
|
|
K
930
DELISTED
Kellanova
K
| $31.6M | ﹤0.01% |
385,687
+2,987
| +0.8% | +$238K |
|
931
ADMA Biologics
ADMA
$2.11B
| $31.6M | ﹤0.01% |
2,155,662
+16,422
| +0.8% | +$281K |
|
932
Universal Technical Institute
UTI
$1.42B
| $31.5M | ﹤0.01% |
968,464
+931,489
| +2,519% | +$27.4M |
|
933
Travel + Leisure Co
TNL
$4.58B
| $31.3M | ﹤0.01% |
525,919
+34,016
| +7% | +$2.04M |
|
934
Box
BOX
$4.66B
| $31.3M | ﹤0.01% |
968,863
-77,203
| -7% | -$2.5M |
|
935
Procept Biorobotics
PRCT
$1.26B
| $31.2M | ﹤0.01% |
875,181
-447,258
| -34% | -$20.4M |
|
936
Church & Dwight Co
CHD
$24B
| $31M | ﹤0.01% |
354,147
-2,096
| -0.6% | -$196K |
|
937
Hecla Mining
HL
$11.9B
| $31M | ﹤0.01% |
2,559,470
+1,977,735
| +340% | +$15.9M |
|
938
Janux Therapeutics
JANX
$978M
| $30.9M | ﹤0.01% |
1,265,556
-527,871
| -29% | -$12.9M |
|
|
GTM
939
ZoomInfo Technologies
GTM
$1.25B
| $30.9M | ﹤0.01% |
2,833,222
+2,614,810
| +1,197% | +$28M |
|
940
Edison International
EIX
$27.2B
| $30.8M | ﹤0.01% |
557,470
+238
| +0% | +$12.8K |
|
941
Griffon
GFF
$4.8B
| $30.7M | ﹤0.01% |
403,018
+1,486
| +0.4% | +$115K |
|
942
Unity
U
$20.2B
| $30.6M | ﹤0.01% |
764,188
+528,285
| +224% | +$19.6M |
|
943
Joby Aviation
JOBY
$8.17B
| $30.2M | ﹤0.01% |
1,872,086
+899,713
| +93% | +$13.7M |
|
944
IDEAYA Biosciences
IDYA
$3.53B
| $30.2M | ﹤0.01% |
1,109,740
-795,176
| -42% | -$19.2M |
|
945
Biohaven
BHVN
$2.24B
| $30.2M | ﹤0.01% |
2,009,611
-1,161,624
| -37% | -$16.9M |
|
946
West Pharmaceutical
WST
$24.4B
| $30.1M | ﹤0.01% |
114,545
-3,084
| -3% | -$750K |
|
947
Halliburton
HAL
$27.4B
| $30M | ﹤0.01% |
1,220,336
-21,059
| -2% | -$466K |
|
948
Allison Transmission
ALSN
$10.2B
| $29.9M | ﹤0.01% |
352,580
+35,100
| +11% | +$3.12M |
|
949
Apogee Therapeutics
APGE
$10.2B
| $29.8M | ﹤0.01% |
750,529
-10,315
| -1% | -$394K |
|
950
Wave Life Sciences
WVE
$1.02B
| $29.6M | ﹤0.01% |
4,044,492
-1,145,911
| -22% | -$9.27M |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.